Long-Term Safety of Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients
X. Green(Johns Hopkins University), William A. Werbel(Johns Hopkins University), W. Gallo(Johns Hopkins University), M. Chahoud(Johns Hopkins University), Chadi A. Hage(Indiana University – Purdue University Indianapolis), Andrew H. Karaba(Johns Hopkins University)
Cited by 0
Related Papers
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
|JAMA|2021|1k
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
|JAMA|2021|536
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
|Annals of Internal Medicine|2021|359
Early impact of COVID-19 on transplant center practices and policies in the United States
|American Journal of Transplantation|2020|244